Cost-effectiveness, budget impact and decision models for payers and HTA bodies.
Studies that measure what matters to patients and health systems, from burden of illness to comparative effectiveness.
Planning the evidence an asset will need to secure access, from early development onward.
Systematic reviews, indirect comparisons and the dossiers that go to national and joint assessments.
Designing and validating the outcome measures used in trials and value arguments.
Specialist HEOR agencies and consultancies serving manufacturers.
We're not advertising roles in this area right now, but we're always speaking with clients and candidates. Get in touch for a confidential conversation.